Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

A new study suggests an impact of the COVID-19 vaccine on SARS-CoV-2 attack rate, and hospitalizations, even with no protection against infection.

14 Dec 2020

Less sensitive rapid tests may miss asymptomatic/presymptomatic SARS-CoV-2 infection

The rapid transmissibility of SARS-CoV-2 has posed a significant challenge to COVID-19 containment measures.

14 Dec 2020

Risk factors for COVID-19 vaccine acceptance

A recent study adds more evidence to the supposition that willingness to accept the COVID-19 vaccine depends on a variety of factors.

14 Dec 2020

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Researchers in the United States and Australia have conducted a comprehensive analysis of the epitope recognition patterns associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans.

14 Dec 2020

60-second breath test to detect COVID-19 with IONICON PTR-TOFMS

Singapore start-up develops fast breath test based on PTR-TOF technology.

From Ionicon Analytik Ges.m.b.H. 14 Dec 2020

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Scientists have suggested that a proportion of the population have pre-existing immunity to COVID-19 because of T cells primed against SARS-CoV-2 antigens.

14 Dec 2020

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

In the current COVID-19 pandemic, SARS-CoV-2 has led to millions of infections worldwide, with over 1.5 million deaths.

14 Dec 2020

SARS-CoV-2 Nsp3 protease activity and nanobody inhibitor development

A new study published in the pre-print server bioRxiv* explores the viral enzyme PLpro, encoded in the nonstructural protein nsp3, and its inhibitors. T

14 Dec 2020

RNA editing within host linked to SARS-CoV-2 variants

Since the start of the COVID-19 pandemic, the causative virus, SARS-CoV-2, has undergone several mutations.

14 Dec 2020

Households are a high-risk setting for SARS-CoV-2 transmission

The results of a new study have confirmed that households, and other crowded indoor environments, are high-risk settings for SARS-CoV-2 transmission.

14 Dec 2020

Experts debate how to transform services to improve UK mental health support

New research into the concerns of people with healthcare needs amid COVID-19 were explored, as a panel of industry leaders debated how to transform services to improve UK mental health support, in Connect Health’s latest Change webinar.

14 Dec 2020

Report: COVID-19 has had little positive impact on perceptions of pharmaceutical companies

A report launched today by pharmaceutical company Takeda UK reveals that, despite heightened public and media attention on the industry’s efforts to develop vaccines and treatments, the COVID-19 pandemic has had little positive impact on perceptions of pharmaceutical companies.

14 Dec 2020

Study: Lack of water puts health care workers and patients at higher risk of COVID-19 infection

Around 1.8 billion people are at heightened risk of COVID-19 and other diseases because they use or work in health care facilities without basic water services, warn WHO and UNICEF.

14 Dec 2020

£453,000 grant awarded to boost research and development for COVID-19 antibodies

Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queen’s University Belfast, leader in innovation and impact, have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts.

14 Dec 2020

Digital chest drainage systems could help reduce COVID-19 spread, research shows

Pioneering research, which reveals digital chest drains generate and distribute less aerosol generated particles compared to traditional water seal systems, has been published in the Seminars in Thoracic and Cardiovascular Surgery journal.

14 Dec 2020

Wastewater testing can detect COVID-19 cases weeks before people show clinical signs

A new study from Australia’s national science agency, CSIRO, and the University of Queensland provides further evidence that wastewater (untreated sewage) testing can detect COVID-19 in communities weeks before people display symptoms, suggesting this testing could provide a targeted early detection system as economies re-open and people become more mobile.

14 Dec 2020

Expansion of telepsychiatry may outlast the COVID-19 pandemic

Once the COVID-19 pandemic is over, a lot of things will go back to normal. We'll stop wearing masks. We'll crowd into restaurants. We'll walk whatever direction we want to down grocery store aisles. But some changes that the pandemic spurred might be here to stay. Among them: the expansion of telepsychiatry.

11 Dec 2020

Study: Most pregnant patients who tested positive for coronavirus were asymptomatic

The majority of pregnant women who tested positive for COVID-19 on arrival to the delivery room were asymptomatic, according to a paper by Mount Sinai researchers published in PLOS One on Thursday, December 10.

11 Dec 2020

WVU, DHHR team up to create new COVID-19 testing laboratory in Morgantown

To address the challenges of COVID-19 testing shortages and lagging turnaround times, West Virginia University and the West Virginia Department of Health and Human Resources have teamed up to create a new testing laboratory at the Health Sciences Center thanks to funding made possible by Gov. Jim Justice.

11 Dec 2020

Access to outdoor spaces benefits mental health, wellbeing during COVID-19 lockdown

People in European countries with the strictest COVID-19 lockdown policies were more likely to show symptoms of depression and anxiety, according to an international study investigating the impact of disconnecting from nature.

11 Dec 2020

Pandemic News and Research

Further Reading

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

Less sensitive rapid tests may miss asymptomatic/presymptomatic SARS-CoV-2 infection

Risk factors for COVID-19 vaccine acceptance

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

60-second breath test to detect COVID-19 with IONICON PTR-TOFMS

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

D614G mutation promotes lysosomal trafficking of SARS-CoV-2 spike protein

SARS-CoV-2 Nsp3 protease activity and nanobody inhibitor development

RNA editing within host linked to SARS-CoV-2 variants

Households are a high-risk setting for SARS-CoV-2 transmission

Experts debate how to transform services to improve UK mental health support

Report: COVID-19 has had little positive impact on perceptions of pharmaceutical companies

Study: Lack of water puts health care workers and patients at higher risk of COVID-19 infection

£453,000 grant awarded to boost research and development for COVID-19 antibodies

Digital chest drainage systems could help reduce COVID-19 spread, research shows

Wastewater testing can detect COVID-19 cases weeks before people show clinical signs

Expansion of telepsychiatry may outlast the COVID-19 pandemic

Study: Most pregnant patients who tested positive for coronavirus were asymptomatic

WVU, DHHR team up to create new COVID-19 testing laboratory in Morgantown

Access to outdoor spaces benefits mental health, wellbeing during COVID-19 lockdown

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News